Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000963281 | SCV001110429 | likely benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547282 | SCV003754762 | benign | Inborn genetic diseases | 2021-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000963281 | SCV004701443 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SCYL1: BS2 |
Breakthrough Genomics, |
RCV000963281 | SCV005211323 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003905859 | SCV004726890 | benign | SCYL1-related disorder | 2020-03-06 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |